Poster Presentations 2019
DOI: 10.1136/annrheumdis-2019-eular.8044
|View full text |Cite
|
Sign up to set email alerts
|

Thu0547 fibrodysplasia Ossificans Progressiva in Pediatric Rheumatology Practice: Large Series Experience of the Single Center

Abstract: BackgroundFibrodysplasia Ossificans Progressiva (FOP), also known as a “second skeleton disease” is extremely rare (1: 2000000) and disabling genetic disorder, caused by mutation of ACVR1 gene, a bone morphogenetic protein receptor. Among medical specialties there are no certain, capable to provide not only diagnostics, but also all medical maintenance (assessment and monitoring of extent of damages, the differentiated drug treatment, rehabilitation, contact with adjacent experts). It would be reasonable if th… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles